Is a complete SBFM research report available?

No complete published report is available for Sunshine Biopharma, Inc. (SBFM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · USD

$3.08

+0.12 (+4.0%)· Recorded snapshot

Market cap	597.1K
Revenue (ttm)	35.3M
Net income (ttm)	-5.8M
EPS (ttm)	-$164
Shares out	193.9K
Volume	214,205
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.3M
Net income (ttm): -5.8M
EPS (ttm): -$164
Market cap: 597.1K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001402328
Company name	Sunshine Biopharma, Inc.
Country	United States
Country code	US
CUSIP number	867781809
Earnings date	2026-11-12
Earnings time	amc
Employees	50
Employees change	-2
Employees growth	-3.85%
Enterprise value	$-12.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US8677818093
Last 10-K release date	2026-04-03
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-10-26
Last stock split type	Reverse
Market cap	$597,107
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$3.08
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SBFM
U.S. state	Florida
Website	https://sunshinebiopharma.com

Metric

Value

Amount currency

USD

CIK code

0001402328

Company name

Sunshine Biopharma, Inc.

Country

United States

Country code

CUSIP number

867781809

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-2

Employees growth

-3.85%

Enterprise value

$-12.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US8677818093

Last 10-K release date

2026-04-03

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-10-26

Last stock split type

Reverse

Market cap

$597,107

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$3.08

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SBFM

U.S. state

Florida

Website

https://sunshinebiopharma.com

Metric	Value
Earnings yield	-5,321.69%
FCF / EV yield	42.04%
FCF yield	-936.13%
Forward P/S	0.03x
Industry forward P/E	13.59x
Industry P/E	175.96x
P/B ratio	0.01x
P/S ratio	0.02x
Price / tangible book value	0.02x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-5,321.69%

FCF / EV yield

42.04%

FCF yield

-936.13%

Forward P/S

0.03x

Industry forward P/E

13.59x

Industry P/E

175.96x

P/B ratio

0.01x

P/S ratio

0.02x

Price / tangible book value

0.02x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-14.71%
EBITDA margin	-13.72%
Gross margin	30.3%
Operating margin	-14.71%
Pretax margin	-15.73%
Profit margin	-16.5%
Profit per employee	$-116,653
Revenue per employee	$706,935
ROA	-9.91%
ROA (5Y)	-32.15%
ROCE	-18.56%
ROE	-21.92%
ROIC	-11.85%
SBC / revenue	0.27%
Tax / revenue	0.77%

Metric

Value

EBIT margin

-14.71%

EBITDA margin

-13.72%

Gross margin

30.3%

Operating margin

-14.71%

Pretax margin

-15.73%

Profit margin

-16.5%

Profit per employee

$-116,653

Revenue per employee

$706,935

ROA

-9.91%

ROA (5Y)

-32.15%

ROCE

-18.56%

ROE

-21.92%

ROIC

-11.85%

SBC / revenue

0.27%

Tax / revenue

0.77%

Metric	Value
EPS growth quarters	2
EPS growth years	4
Gross profit growth	-11.58%
Gross profit growth (Q)	-29.1%
Gross profit growth 3Y	26.12%
Gross profit growth 5Y	163.53%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-2.74%
Revenue growth (Q)	-1.56%
Revenue growth (QoQ)	14.53%
Revenue growth 3Y	34.5%
Revenue growth 5Y	203.13%
Revenue growth years	6

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-11.58%

Gross profit growth (Q)

-29.1%

Gross profit growth 3Y

26.12%

Gross profit growth 5Y

163.53%

Net income growth quarters

Net income growth years

Revenue growth

-2.74%

Revenue growth (Q)

-1.56%

Revenue growth (QoQ)

14.53%

Revenue growth 3Y

34.5%

Revenue growth 5Y

203.13%

Revenue growth years

Metric	Value
Capital expenditures	$-19,145
Depreciation and amortization	$349,667
EBIT	$-5.2M
EBITDA	$-4.8M
EPS	$-163.91
FCF per share	$-27.71
Financing cash flow	$8.5M
Free cash flow	$-5.4M
Free cash flow minus SBC	$-5.5M
Gross profit	$10.7M
Income taxes	$270,936
Investing cash flow	$-183,740
Net cash flow	$3.4M
Net income	$-5.8M
Operating cash flow minus SBC	$-5.4M
Operating income	$-5.2M
Revenue	$35.3M
Stock-based compensation	$96,900

Metric

Value

Capital expenditures

$-19,145

Depreciation and amortization

$349,667

EBIT

$-5.2M

EBITDA

$-4.8M

EPS

$-163.91

FCF per share

$-27.71

Financing cash flow

$8.5M

Free cash flow

$-5.4M

Free cash flow minus SBC

$-5.5M

Gross profit

$10.7M

Income taxes

$270,936

Investing cash flow

$-183,740

Net cash flow

$3.4M

Net income

$-5.8M

Operating cash flow minus SBC

$-5.4M

Operating income

$-5.2M

Revenue

$35.3M

Stock-based compensation

$96,900

Metric	Value
Altman Z-Score	-1.18
Book value per share	$230.48
Debt / equity	0.02
Long-term assets	$3M
Long-term liabilities	$475,820
Net cash (debt)	$13.4M
Net cash / market cap	2,326.67%
Net cash growth	42.4%
Net debt / equity	-0.48
Piotroski F-Score	2
Property, plant and equipment	$1.1M
Shareholders' equity	$27.5M
Tangible book value	$25.7M
Tangible book value per share	$215.05
Total assets	$33.6M
Total cash	$14M
Total debt	$678,338
Total liabilities	$6.1M
WACC	5.36%

Metric

Value

Altman Z-Score

-1.18

Book value per share

$230.48

Debt / equity

0.02

Long-term assets

$3M

Long-term liabilities

$475,820

Net cash (debt)

$13.4M

Net cash / market cap

2,326.67%

Net cash growth

42.4%

Net debt / equity

-0.48

Piotroski F-Score

Property, plant and equipment

$1.1M

Shareholders' equity

$27.5M

Tangible book value

$25.7M

Tangible book value per share

$215.05

Total assets

$33.6M

Total cash

$14M

Total debt

$678,338

Total liabilities

$6.1M

WACC

5.36%

Metric	Value
Asset turnover	1.08
Current assets	$30.7M
Current liabilities	$5.6M
Current ratio	5.46
Inventory turnover	1.96
Net working capital	$11.2M
Quick ratio	3.21
Working capital	$25M
Working capital turnover	1.49

Metric

Value

Asset turnover

1.08

Current assets

$30.7M

Current liabilities

$5.6M

Current ratio

5.46

Inventory turnover

1.96

Net working capital

$11.2M

Quick ratio

3.21

Working capital

$25M

Working capital turnover

1.49

Metric	Value
Buyback yield / dilution	-186.54%
Dividend yield	0%
Shareholder yield	-186.54%

Metric

Value

Buyback yield / dilution

-186.54%

Dividend yield

Shareholder yield

-186.54%

Metric	Value
10Y price change	-100%
10Y return CAGR	-77.28%
10Y total return	-100%
150-day SMA	$70.59
15Y price change	-100%
15Y return CAGR	-72.61%
15Y total return	-100%
1D price change	4.05%
1M price change	-81.87%
1M total return	-81.87%
1W price change	-30.55%
1W total return	-30.55%
1Y price change	-99.22%
1Y return CAGR	-99.22%
1Y total return	-99.22%
20-day SMA	$6.30
200-day SMA	$111.48
3M price change	-90.01%
3M total return	-90.01%
3Y price change	-100%
3Y return CAGR	-97.12%
3Y total return	-100%
50-day SMA	$14.97
50-day SMA vs 200-day SMA	50under200
52-week high	$464.00
52-week high date	2026-05-18
52-week low	$2.58
52-week low date	2026-10-26
5Y price change	-100%
5Y return CAGR	-94.6%
5Y total return	-100%
6M price change	-98.44%
6M total return	-98.44%
All-time high	$2,416,666,666.67
All-time high date	2011-08-02
All-time low	$2.58
All-time low date	2026-10-26
Average true range (ATR)	$1.79
Average volume	868.1K
Beta (1Y)	1.11
Beta (2Y)	1.7
Beta (5Y)	1.35
Change from 52-week high	-99.34%
Change from 52-week low	19.38%
Change from all-time high	-100%
Change from all-time low	18.45%
Change from open	1.32%
Day's gap	2.7%
Dollar volume	$659,751
High price	$3.10
Low price	$2.89
Monthly RSI	39.31
Open price	$3.04
Position in 52-week range	90.48%
Premarket change	-1.69%
Premarket close	$2.96
Premarket price	$2.91
Premarket volume	76.9K
Previous close	$2.96
Price vs 150-day SMA	-95.67%
Price vs 20-day SMA	-51.49%
Price vs 200-day SMA	-97.26%
Price vs 50-day SMA	-79.58%
Relative volume	0.25
RSI	26.65
Sharpe ratio	-2.16
Sharpe ratio (3Y)	-1.52
Sharpe ratio (5Y)	-0.87
Sortino ratio	-3.14
Sortino ratio (3Y)	-2.18
Sortino ratio (5Y)	-1.48
Volume	214.2K
Weekly RSI	19.45
YTD price change	-98.76%
YTD total return	-98.76%

Metric

Value

10Y price change

-100%

10Y return CAGR

-77.28%

10Y total return

-100%

150-day SMA

$70.59

15Y price change

-100%

15Y return CAGR

-72.61%

15Y total return

-100%

1D price change

4.05%

1M price change

-81.87%

1M total return

-81.87%

1W price change

-30.55%

1W total return

-30.55%

1Y price change

-99.22%

1Y return CAGR

-99.22%

1Y total return

-99.22%

20-day SMA

$6.30

200-day SMA

$111.48

3M price change

-90.01%

3M total return

-90.01%

3Y price change

-100%

3Y return CAGR

-97.12%

3Y total return

-100%

50-day SMA

$14.97

50-day SMA vs 200-day SMA

50under200

52-week high

$464.00

52-week high date

2026-05-18

52-week low

$2.58

52-week low date

2026-10-26

5Y price change

-100%

5Y return CAGR

-94.6%

5Y total return

-100%

6M price change

-98.44%

6M total return

-98.44%

All-time high

$2,416,666,666.67

All-time high date

2011-08-02

All-time low

$2.58

All-time low date

2026-10-26

Average true range (ATR)

$1.79

Average volume

868.1K

Beta (1Y)

1.11

Beta (2Y)

1.7

Beta (5Y)

1.35

Change from 52-week high

-99.34%

Change from 52-week low

19.38%

Change from all-time high

-100%

Change from all-time low

18.45%

Change from open

1.32%

Day's gap

2.7%

Dollar volume

$659,751

High price

$3.10

Low price

$2.89

Monthly RSI

39.31

Open price

$3.04

Position in 52-week range

90.48%

Premarket change

-1.69%

Premarket close

$2.96

Premarket price

$2.91

Premarket volume

76.9K

Previous close

$2.96

Price vs 150-day SMA

-95.67%

Price vs 20-day SMA

-51.49%

Price vs 200-day SMA

-97.26%

Price vs 50-day SMA

-79.58%

Relative volume

0.25

RSI

26.65

Sharpe ratio

-2.16

Sharpe ratio (3Y)

-1.52

Sharpe ratio (5Y)

-0.87

Sortino ratio

-3.14

Sortino ratio (3Y)

-2.18

Sortino ratio (5Y)

-1.48

Volume

214.2K

Weekly RSI

19.45

YTD price change

-98.76%

YTD total return

-98.76%

Metric	Value
Float	145K
Float percentage	74.79%
Shares change (QoQ)	178.3%
Shares change (YoY)	186.54%
Shares held by insiders	1.76%
Shares held by institutions	26.75%
Shares outstanding	193.9K
Short % of float	90.68%
Short % of shares	67.82%
Short ratio	0.9 days

Metric

Value

Float

145K

Float percentage

74.79%

Shares change (QoQ)

178.3%

Shares change (YoY)

186.54%

Shares held by insiders

1.76%

Shares held by institutions

26.75%

Shares outstanding

193.9K

Short % of float

90.68%

Short % of shares

67.82%

Short ratio

0.9 days

Sunshine Biopharma, Inc. (SBFM)

Price

Financial snapshot

Fair-value bridge

Latest news · SBFM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SBFM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SBFM

Frequently asked questions